Skip to main content

Table 2 Gene expression profile of human B cells modulated by TLR7, 8, or 9 agonists from 3 different donors (maximum fold-change through a 2, 8, 24 hour time course).

From: Comparison of human B cell activation by TLR7 and TLR9 agonists

Gene

Alias

3M-006

3M-002

852A

3M-003

CpG 2006

  

D1

D2

D3

D1

D2

D3

D1

D2

D3

D1

D2

D3

D1

D2

D3

FCGR2B

CD32

-1.2

-1.7

-1.2

-1.3

-1.9

-1.3

-2.6

-4.7

-2.1

-7.4

-19.1

-8.4

-6.7

-22.8

-8.6

GBP2

GBP2

-1.1

-1.5

1.0

-1.1

-1.9

1.0

-2.8

-5.0

-2.3

-3.5

-13.4

-7.1

-2.6

-1.7

-1.8

CD72

Ly-19

-1.5

1.2

1.4

-1.1

-1.2

1.4

-3.2

-3.9

-1.8

-5.1

-9.1

-4.4

-3.5

-5.8

-2.9

GAPDH

GAPDH

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

1.0*

IL12B

IL12p40

-1.1

1.3

1.2

8.5

1.5

1.1

9.1

-1.1

2.5

16.1

1.3

3.7

11.4

-1.2

1.6

FCER2

CD23

-1.1

-1.4

-1.3

1.6

1.4

1.5

3.1

1.7

2.9

7.0

2.3

5.4

3.5

1.1

3.7

CCL20

MIP3a

-1.2

-1.2

1.2

52.3

6.7

1.3

2.9

-1.6

1.0

28.6

2.6

1.4

-2.9

-2.1

1.0

IL-1B

IL1F2

-1.7

-1.6

-1.8

31.1

8.2

29.1

2.6

1.7

2.8

28.8

5.4

9.8

3.9

-1.7

3.2

COX-2

PTGS2

-1.2

-2.8

1.3

21.7

5.0

2.0

-2.7

2.0

2.7

16.8

3.6

5.6

4.9

8.3

2.2

CD86

B7-2

-1.2

-1.2

1.2

1.2

1.3

1.3

2.1

2.3

2.3

2.8

5.0

4.1

1.6

3.8

1.9

CD40

TNFRSF5

1.1

1.1

1.1

1.6

1.6

1.6

3.7

2.6

3.1

6.1

4.7

6.0

4.7

4.0

3.0

FOS

c-fos

1.1

1.4

1.6

-1.3

1.6

1.8

-2.0

2.8

2.7

-3.7

4.7

6.1

-2.7

-2.0

-1.6

GOS-2

RP1

-1.4

-1.4

2.0

2.3

2.0

2.6

3.1

2.7

4.4

6.3

4.5

10.0

5.3

5.1

7.5

NFKB1A

IKBA

1.1

1.5

1.4

1.9

1.7

2.2

3.8

3.8

4.2

4.8

4.2

6.6

4.0

4.2

5.4

TR3

TNFRSF25

1.3

1.8

1.6

1.2

1.9

2.1

1.5

4.0

3.5

-2.7

3.2

5.6

2.0

3.6

-1.5

CD58

LFA3

1.1

1.2

1.2

1.3

1.5

1.6

2.0

3.8

3.2

3.3

4.8

5.0

3.2

5.2

5.5

IL21r

NILR

1.3

1.4

1.3

1.7

2.2

2.2

3.5

4.7

5.4

4.9

5.7

6.7

4.0

5.1

6.3

MYC

c-myc

-1.2

1.4

1.4

1.6

1.7

1.9

2.1

3.7

3.2

3.5

7.0

10.7

3.6

12.3

8.1

CD80

B7-1

1.2

1.4

1.2

2.0

1.9

1.8

3.9

4.8

3.8

7.3

8.6

8.1

6.1

6.9

6.4

TNFa

TNFSF2

-1.2

1.4

1.2

3.1

2.2

1.7

9.5

6.9

7.7

14.9

10.3

16.2

13.8

11.8

7.0

IL1a

IL1F1

-1.7

1.5

1.2

2.5

4.5

1.5

4.0

4.3

2.8

5.7

11.4

6.8

4.6

11.7

2.9

CCL4

MIP1b

1.4

1.0

1.2

3.3

2.3

3.0

6.1

7.1

5.7

10.8

10.9

32.6

22.3

38.6

37.4

CCL3

MIP1a

1.2

1.2

1.5

4.5

2.4

2.9

11.4

10.0

10.1

18.9

15.6

45.6

39.3

45.6

62.3

BFCL2L1

Bcl-xl

-1.3

-1.1

1.3

1.9

1.8

2.1

4.5

8.3

6.4

6.1

21.7

15.1

5.1

12.8

9.2

DSP2

PAC1

1.3

1.5

1.2

1.2

2.8

2.0

2.3

10.8

4.6

4.0

16.1

18.3

3.7

13.5

5.0

LTA

TNFSF1

1.0

1.3

1.3

6.1

2.5

2.5

63.0

18.8

24.3

85.8

18.5

32.0

55.5

22.1

24.9

TCFL5

E2BP1

-1.2

1.3

1.2

1.6

3.1

2.0

9.7

17.7

9.4

22.6

25.2

24.9

16.3

23.5

18.7

IL-6

IFNB2

1.9

2.4

1.0

7.0

4.7

6.1

24.9

25.6

40.4

70.8

51.3

71.9

58.9

59.4

53.2

  1. (a) normal text = subjectively assigned nominal to low fold change (-3.4 to 3.4).
  2. (b) bold text, negative values = subjectively assigned moderate fold suppression (-23.0 to -3.5).
  3. (c) bold text, positive values = subjectively assigned moderate to high fold increase (3.5 to 86.0).
  4. (d) text with * = GAPDH, house keeping gene as a reference.